Overview
The goal of this study is to validate the TAPS-ESP as a screen and assessment that can be used in primary care for the screening and treatment of substance use.
Description
This Phase II study seeks to conduct further research to validate the TAPS-ESP as a Spanish language version of the screening and brief assessment and pave the way for its broad dissemination in the healthcare system. The investigators will use a novel application of a Type 1 hybrid effectiveness-implementation design, adapted to a screening validation study. The investigators will conduct a large-scale study to validate the TAPS-ESP against established diagnostic and biomarker metrics, replicating the design of the seminal English-language TAPS study.
Eligibility
Inclusion Criteria:
- Age 18 or older
- Current patient of the clinic
- Spanish-language preferred
- Ability to read Spanish
Exclusion Criteria:
- Unable to provide informed consent
- Inability to comprehend or read Spanish
- Inability to self-administer the iPad tool due to physical limitations